OPK Biotech  
OPK Biotech websites
Company Technology Research & Development Hemopure Oxyglobin Contact OPK Biotech
Technology & Products - Innovative Research in Oxygen Therapeutics
Home > Research & Development > Anemia

Anemia

Anemia - a decrease in the concentration of red blood cells or hemoglobin in circulation caused by blood loss for example, from injury or surgery, or by other causes, such as disease or chemotherapy treatment.

The Company has also decided to draw on the body of research it has amassed in preclinical and clinical studies involving anemia in surgery patients to develop new indications. One possible usage would examine Hemopure's potential, owing to its oxygen-carrying capacity, to increase perfusion and improve the quality of life in patients with advanced life-limiting illness. Anemia is a significant but understudied problem in terminally ill patients. In a recent study of 105 palliative care patients, of whom 95 had advanced cancer, anemia was found in 77% of men and 68% of women.

HBOCLAB.com
is a Resource Guide for individuals interested in the impact of OPK Biotech's Hemoglobin Based Oxygen Carriers (HBOCs) on laboratory assays. The information presented for Hemopure® also applies to Oxyglobin®.

Learn More
Hemopure
Hemopure® has been used to treat surgical anemia in South Africa since 2001.

Learn More

Oxyglobin
Oxyglobin® Solution

More than
200,000 units
have been
sold in the
United
States and
Europe.

Learn More